DK234489A - Farmaceutisk praeparat indeholdende et immunosuppressivt middel - Google Patents

Farmaceutisk praeparat indeholdende et immunosuppressivt middel Download PDF

Info

Publication number
DK234489A
DK234489A DK234489A DK234489A DK234489A DK 234489 A DK234489 A DK 234489A DK 234489 A DK234489 A DK 234489A DK 234489 A DK234489 A DK 234489A DK 234489 A DK234489 A DK 234489A
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
preparation containing
immunosuppressive agent
immunosuppressive
agent
Prior art date
Application number
DK234489A
Other languages
Danish (da)
English (en)
Other versions
DK234489D0 (da
Inventor
Terry L Bowlin
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK234489D0 publication Critical patent/DK234489D0/da
Publication of DK234489A publication Critical patent/DK234489A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK234489A 1988-05-13 1989-05-12 Farmaceutisk praeparat indeholdende et immunosuppressivt middel DK234489A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/193,847 US5013719A (en) 1988-05-13 1988-05-13 Method of effecting immunosuppression

Publications (2)

Publication Number Publication Date
DK234489D0 DK234489D0 (da) 1989-05-12
DK234489A true DK234489A (da) 1989-11-14

Family

ID=22715265

Family Applications (1)

Application Number Title Priority Date Filing Date
DK234489A DK234489A (da) 1988-05-13 1989-05-12 Farmaceutisk praeparat indeholdende et immunosuppressivt middel

Country Status (7)

Country Link
US (1) US5013719A (de)
EP (1) EP0341624A3 (de)
JP (1) JPH02117622A (de)
KR (1) KR900017595A (de)
AU (1) AU615745B2 (de)
DK (1) DK234489A (de)
ZA (1) ZA893388B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva
US5362629A (en) * 1991-08-05 1994-11-08 President And Fellows Of Harvard College Detection of immunosuppressants
RU2058553C1 (ru) * 1994-03-18 1996-04-20 Иван Николаевич Головистиков Способ определения супрессорного звена иммунного статуса человека
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
US5851537A (en) * 1996-02-02 1998-12-22 Cancer Technologies, Inc. Topical application of α-DFMO for preventing skin cancer
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
JP4261049B2 (ja) 1997-10-08 2009-04-30 アイソテクニカ インコーポレイテッド 重水素化シクロスポリンアナログおよび免疫調節剤としてのそれらの使用
PL210795B1 (pl) 2001-10-19 2012-03-30 Isotechnika Inc Sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (E), sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (Z), sposób stereoselektywnej syntezy izomeru (E) ISATX247, sposób stereoselektywnej syntezy izomeru (Z) ISATX247 i sposób wytwarzania mieszaniny izomerów ISATX247
US20030129208A1 (en) * 2002-01-07 2003-07-10 Alberts David S. Topical application of alpha-DFMO and anti-inflammatory drug for treatment of actinic keratoses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
CA1121375A (en) * 1977-07-01 1982-04-06 Brian W. Metcalf Derivatives of amines and amino acids
US4139563A (en) * 1977-07-01 1979-02-13 Merrell Toraude Et Compagnie α-ACETYLENIC DERIVATIVES OF AMINES
US4413141A (en) * 1977-07-11 1983-11-01 Merrell Toraude Et Compagnie 2-(Difluoromethyl)-2,5-diaminopentanoic acid
US4499072A (en) * 1982-11-29 1985-02-12 Merrell Dow Pharmaceuticals Inc. Process for treating diseases with ODC inhibitors
EP0300675A3 (de) * 1987-07-21 1990-04-11 Merck Frosst Canada Inc. Methode zur Verbesserung der Cyclosporintherapie

Also Published As

Publication number Publication date
EP0341624A3 (de) 1991-06-05
EP0341624A2 (de) 1989-11-15
ZA893388B (en) 1990-01-31
US5013719A (en) 1991-05-07
KR900017595A (ko) 1990-12-19
AU615745B2 (en) 1991-10-10
JPH02117622A (ja) 1990-05-02
DK234489D0 (da) 1989-05-12
AU3473689A (en) 1989-11-16

Similar Documents

Publication Publication Date Title
DK229489A (da) Laegemiddeladsorbater
DK481989D0 (da) Farmaceutiske formuleringer
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
DK128789A (da) Immunosuppressivt praeparat
DK360988A (da) Farmaceutiske cyclodextrinholdige praeparater
DE10199066I1 (de) Pharmazeutische Zusammensetzung
AU674185B2 (en) Platinum pharmaceutical agents
LV10573A (lv) Panemiens farmaceitiska sastava iegusanai
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
DK435688D0 (da) Farmaceutiske midler
IT8922216A0 (it) Soluzione farmaceutica
DK234489A (da) Farmaceutisk praeparat indeholdende et immunosuppressivt middel
DK521487D0 (da) Farmaceutisk praeparat indeholdende et resorptionsforbedrende middel
DK336489D0 (da) Farmaceutisk praeparat
DK273187A (da) Farmaceutiske praeparater indeholdende naphthyridinderivater
DK670388A (da) Antibiotikumholdigt farmaceutisk praeparat
DK205590D0 (da) Farmaceutisk nifedipinholdigt praeparat
DK37589D0 (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
KR920007598U (ko) 의약용 캅셀
PT85350B (de) Xylometazolinhaltige pharmazeutische praeparate
LV5735B4 (lv) Medikamenti
DK50288A (da) Anvendelse af et benzo-c-phenanthridinalkaloid til fremstilling af et farmaceutisk middel
NO904611D0 (no) Farmasoeytiske preparater inneholdende deoksyribonukleosider for saarheling.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment